Cargando…

Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies

Magnesium, an essential mineral for human health, plays a pivotal role in the cardiovascular system. Epidemiological studies in the general population have found an association between lower dietary magnesium intake and an elevated risk of cardiovascular events. In addition, magnesium supplementatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakaguchi, Yusuke, Hamano, Takayuki, Isaka, Yoshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331543/ https://www.ncbi.nlm.nih.gov/pubmed/28178182 http://dx.doi.org/10.3390/nu9020112

Ejemplares similares

Prevalence and Prognostic Implications of Vitamin D Deficiency in Chronic Kidney Disease
por: Obi, Yoshitsugu, et al.
Publicado: (2015)

Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease
por: Sakaguchi, Yusuke, et al.
Publicado: (2016)

Low-grade proteinuria and atherosclerotic cardiovascular disease: A transition study of patients with diabetic kidney disease
por: Yamaguchi, Satoshi, et al.
Publicado: (2022)

Plant-Dominant Low Protein Diet: A Potential Alternative Dietary Practice for Patients with Chronic Kidney Disease
por: Sakaguchi, Yusuke, et al.
Publicado: (2023)

Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort study
por: Asahina, Yuta, et al.
Publicado: (2021)

Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease
por: Yonemoto, Sayoko, et al.
Publicado: (2018)

Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients
por: Doi, Yohei, et al.
Publicado: (2020)

Alkali therapy for prevention of acute kidney injury in rhabdomyolysis
por: Kaimori, Jun-Ya, et al.
Publicado: (2022)

Modifying Phosphate Toxicity in Chronic Kidney Disease
por: Vervloet, Marc
Publicado: (2019)

Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney Disease
por: Oka, Tatsufumi, et al.
Publicado: (2022)

Diagnosing metabolic acidosis in chronic kidney disease: importance of blood pH and serum anion gap
por: Kaimori, Jun-Ya, et al.
Publicado: (2022)

Hepatic phosphate uptake and subsequent nerve-mediated phosphaturia are crucial for phosphate homeostasis following portal vein passage of phosphate in rats
por: Yasuda, Seiichi, et al.
Publicado: (2023)

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
por: Sakaguchi, Yusuke, et al.
Publicado: (2014)

Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
por: Iio, Kenichiro, et al.
Publicado: (2019)

Optimal Protein Intake in Pre-Dialysis Chronic Kidney Disease Patients with Sarcopenia: An Overview
por: Isaka, Yoshitaka
Publicado: (2021)

Possible contribution of phosphate to the pathogenesis of chronic kidney disease in dolphins
por: Jahan, Nourin, et al.
Publicado: (2023)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Magnesium Administration in Chronic Kidney Disease
por: Vermeulen, Emma A., et al.
Publicado: (2023)

Quantitative Analyses of Foot Processes, Mitochondria, and Basement Membranes by Structured Illumination Microscopy Using Elastica-Masson– and Periodic-Acid-Schiff–Stained Kidney Sections
por: Matsumoto, Ayumi, et al.
Publicado: (2021)

The emerging role of magnesium in CKD
por: Sakaguchi, Yusuke
Publicado: (2022)

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease
por: Vermeulen, Emma A., et al.
Publicado: (2022)

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
por: Hasegawa, Takeshi, et al.
Publicado: (2023)

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020)

Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling
por: Kimura, Tomonori, et al.
Publicado: (2016)

Dietary casein, egg albumin, and branched-chain amino acids attenuate phosphate-induced renal tubulointerstitial injury in rats
por: Shimada, Karin, et al.
Publicado: (2020)

d-Amino acids and kidney diseases
por: Kimura, Tomonori, et al.
Publicado: (2020)

Use of magnesium as a drug in chronic kidney disease
por: Hutchison, Alastair J., et al.
Publicado: (2012)

Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020)

Targeting TGF-β Signaling in Kidney Fibrosis
por: Isaka, Yoshitaka
Publicado: (2018)

Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis
por: Yamaguchi, Satoshi, et al.
Publicado: (2020)

Phosphate Additive Avoidance in Chronic Kidney Disease
por: St-Jules, David E., et al.
Publicado: (2017)

The Importance of Phosphate Control in Chronic Kidney Disease
por: Tsuchiya, Ken, et al.
Publicado: (2021)

The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
por: Doi, Yohei, et al.
Publicado: (2021)

Single cell RNA sequencing uncovers cellular developmental sequences and novel potential intercellular communications in embryonic kidney
por: Matsui, Isao, et al.
Publicado: (2021)

Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?
por: Leenders, Nicoline H. J., et al.
Publicado: (2019)

Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020)

Decreased thymic output predicts progression of chronic kidney disease
por: Iio, Kenichiro, et al.
Publicado: (2023)

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients
por: Cunningham, John, et al.
Publicado: (2012)

Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes
por: Huang, Jui-Hua, et al.
Publicado: (2015)

Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease
por: Jacobsen, Alexanndra A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2tii7focjeq68doviamc0pehof